Proteinuria-Lowering Effects of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors in Chronic Kidney Disease Patients: A Real-World Multicentric Study

Added 260 days ago (26.11.2021)
Authors: Patricia Muñoz Ramos; Yohana Gil Giraldo; VicenteÁlvarez-Chiva; David Arroyo; Cristina Sango Merino; Francesc Moncho Francés; Javier Ocaña; Javier Reque; Emilio Sánchez-Álvarez; José Luis Górriz; Borja Quiroga
Journal: Metabolites
Read article